Abstract
<ul> <li style="text-align: justify;"><meta charset="UTF-8" />There is considerable variation among cytometry reagents, instruments and analysis approaches used for hematological disease diagnosis and monitoring.</li> <li style="text-align: justify;">We previously demonstrated that our approach is adaptable across different instruments for sample level classification model development.</li> <li style="text-align: justify;">In this study, we combined three different panels: ClearLLab10C, Euroflow AML/MDS and a UPMC diagnostic panel to demonstrate the feasibility of developing sample and cell level classification models thats instrument and reagent agnostic.</li></ul>